Somagenics
Pre-clinicalSomaGenics' sensitive and high-specificity PCR technology allows detection of miRNAs and other small RNAs. The platform is optimized for either biofluids or total RNA inputs.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $7.7M
About
SomaGenics' sensitive and high-specificity PCR technology allows detection of miRNAs and other small RNAs. The platform is optimized for either biofluids or total RNA inputs.
Diagnostics
Funding History
2Total raised:$7.7M
Series A$6.5MAug 15, 2019
Seed$1.2MApr 15, 2016